References
- Brezin J H, Katz S M, Schwartz A B, Chinitz J L. Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1979; 301: 1271–1273
- Johnson W J. Nephrotoxicity of nonsteroidal anti-inflammatory drugs (Editorial). Mayo Clin Proc 1980; 55: 120
- Collet Ph, Beaune J, Llorca P. Nephrotoxicite des antiinflammatoire non-steroidiens. A propos de six observation et d'une revue de la literature. Therapie 1987; 42: 378–385
- Husserl F E, Lange R K, Kantrow C M, Jr. Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. J Am Med Assoc 1979; 242: 1896–1898
- Curt G A, Kaldany A, Whithy L G, Crosson A W, Rolla A, Merino M J, D'Elia J A. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium. Ann Intern Med 1980; 12: 72–73
- Kimberly K P, Bowden R E, Reiser H R, Plotz P H. Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med 1978; 64: 804–807
- McCarthy J T, Torres V E, Romero J C, Wochos DN, Velosa V E. Acute intrinsic renal failure induced by indomethacin: Role of prostaglandin synthetase inhibition. Mayo Clin Proc 1982; 57: 289–296
- Finkelstein A, Fraley D S, Stachura I, Feedman H A, Gandy D R, Bourke E. Fenoprofen nephropathy: Lipoid nephrosis and interstitial nephritis. A Possible T-lymphocyte disorder. Am J Med 1982; 72: 81–87
- Donker AJM, Arisz L, Brentjens JRH, VanDer Hem G H, Hollemans HIG. The effect of indomethacin on kidney function and plasma renin activity. Nephron 1976; 17: 288–296
- Walshe J J, Venuto R C. Acute oliguric renal failure induced by indomethacin: Possible mechanism. Ann Intern Med 1979; 91: 47–49
- Cinotti G A. Clinical assessment of the renal toxicity of anti-rheumatic drugs. Arch Toxicol Suppl 1984; 7: 338–349
- Peters J, Mampe E, Schneider I, Burchard U, Hascher R. Alanine aminopeptidase/alfa-alanin-peptid-hydrolase/im Harn bei Nierenkrankungen. Clin Chim Acta 1972; 37: 213–224
- Szasz G. A kinetic photometric method for serum gamma glu-tamyltranspeptidase. Clin Chim 1969; 15: 124–135
- Maruhn D, Fuchs I, Mues G, Bock R D. Normal limits of excretion of eleven enzymes. Clin Chim 1976; 22: 1567–1572
- Flandrois C, Feldman D, Baltassat P, et al. Evaluation de l'enzymurie comme marqueur de nephrotoxicitè: resultats d'une experience multicentrique. Ann Biol Clin 1989; 47: 340–345
- Ehrich J H, Wuster U, Lutge M, Doering E, Oemar B. Enzymu-rie und nierenkrankungen im Kindesalter. Monatsschr Kinder-heilkd 1986; 134: 832–839
- Collet Ph, Llorca G, Gravagna B, Later D, Lejeune E. Evolution de 1'enzymurie au cours des insuffisances renales aigues deus aux anti-inflammatoires non steroidiens. Rev Rheumatisme 1989; 56: 79–81